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Abstract
Objective
There is a critical need to identify biomarkers and objective outcome measures that can be
used to understand underlying neural mechanisms in autism spectrum disorder (ASD).
Visual evoked potentials (VEPs) offer a noninvasive technique to evaluate the functional
integrity of neural mechanisms, specifically visual pathways, while probing for disease
pathophysiology.
Methods
Transient VEPs (tVEPs) were obtained from 96 unmedicated children, including 37 children
with ASD, 36 typically developing (TD) children, and 23 unaffected siblings (SIBS). A con-
ventional contrast-reversing checkerboard condition was compared to a novel short-dura-
tion condition, which was developed to enable objective data collection from severely
affected populations who are often excluded from electroencephalographic (EEG) studies.
Results
Children with ASD showed significantly smaller amplitudes compared to TD children at two
of the earliest critical VEP components, P60-N75 and N75-P100. SIBS showed intermediate
responses relative to ASD and TD groups. There were no group differences in response
latency. Frequency band analyses indicated significantly weaker responses for the ASD
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group in bands encompassing gamma-wave activity. Ninety-two percent of children with
ASD were able to complete the short-duration condition compared to 68% for the standard
condition.
Conclusions
The current study establishes the utility of a short-duration tVEP test for use in children at
varying levels of functioning and describes neural abnormalities in children with idiopathic
ASD. Implications for excitatory/inhibitory balance as well as the potential application of
VEP for use in clinical trials are discussed.
Introduction
Significant advances in the field of autism spectrumdisorder (ASD) have beenmade over the
past decade, including the identification of approximately 100 causal genes [1, 2], successful
preclinical studies demonstrating treatment efficacy in model systems [3, 4], and the first large-
scale clinical trials currently underway in patients with single-gene forms of ASD. However,
despite these advances, the field continues to rely on behavioral measures for both diagnosis
and treatment monitoring. Validated biomarkers of ASD remain limited and there are no
acceptedmarkers for widespread use [5]. While electrophysiologicalmethods have improved
our understanding of the disorder, these methods are only recently being tested as outcome
measures [6, 7] and studies are often biased towards higher functioning individuals.
This study seeks to examine disease pathophysiology by examining putative γ-aminobutyric
acid (GABA/inhibitory) and glutamatergic (excitatory) activity in children with idiopathic
ASD and their unaffected siblings (SIBS) using visual evoked potentials (VEPs). VEPs offer a
noninvasive, objective, and reliable technique used to assess the functional integrity of visual
pathways and reflect the sum of excitatory and inhibitory postsynaptic potentials occurringon
apical dendrites [8]. The major positive and negative peaks and troughs in VEP waveforms are
considered a reflection of cortical activity and different cellular events [8, 9].
Pharmacological studies provide evidence for the electrogenesis of these electrically evoked
potentials.When GABA-blocking agents are topically applied to the cortex to selectively block
GABAA-mediated inhibition, there is an enhancement of the negative wave and an attenuation
or elimination of the subsequent positive wave. In contrast, when GABA is applied to the cor-
tex, the negative wave is attenuated or eliminated and the subsequent positive wave is enhanced
[10, 11].
While tVEPs have been recorded from individuals with single-gene forms of ASD (e.g., frag-
ile X syndrome (FXS) [12] tuberous sclerosis complex [13] Phelan-McDermid syndrome
(PMS) [14] Rett syndrome [15, 16], no published studies have examined tVEP responses in
children with idiopathic ASD or SIBS. Given the important role balanced excitatory and inhibi-
tory synapses play in healthy brain function [17–20] VEPs provide a method to examine theo-
ries of excitatory/inhibitory (E/I) imbalance in ASD [21]. There is considerable evidence,
ranging from cellular studies to human studies, supporting theories of enhanced excitation and
suppressed inhibition as markers of ASD [21–26] However, our current understanding of sin-
gle-gene causes of ASD, based in large part on findings from animal models, suggests that glu-
tamatergic activity is heightened in certain syndromes (e.g., FXS) [[27] and decreased in others
(e.g., PMS) [28]; these findings highlight the heterogeneity of ASD in which the excitatory and
inhibitory balance is variable. Ultimately, subtyping patients based on their E/I profile may
Transient Visual Evoked Potentials in ASD
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inform personalizedmedical approaches, aid in determining optimal treatment targets and, in
turn, predict treatment responders based on an individual’s baseline profile.
The current study applied a standard contrast-reversing checkerboardVEP test [29] and
aimed to validate a novel short-duration VEP test, which was developed to optimize objective
data collection from difficult to test populations[30]. For both the standard and short-duration
tests, we hypothesized that children with ASD would display weaker responses reflecting an
altered E/I balance as compared to typically developing (TD) controls and expected SIBS to dis-
play an intermediary response. These aims were achieved as described below.
Materials and Methods
Participants
One hundred and ten children between the ages of two and 12 participated in this study. Data
from 14 participants were removed due to: excessive movement or noncompliance (n = 6), fail-
ure to meet diagnostic inclusion/exclusion criteria (n = 5), or presence of a genetic finding
(n = 3). The final sample included usable data from 96 unmedicated children: 37 children with
ASD (5 females,Mage = 6.46 years, SD = 3.19), 36 TD children (16 females,Mage = 5.89 years,
SD = 2.45), and 23 SIBS (10 females,Mage = 8.00 years, SD = 2.34). There was no significant dif-
ference in age between the ASD and TD group, t(71) = -.855, p = .395, however, there was a sig-
nificant difference in age between the SIBS group relative to the ASD, t(58) = -2.00, p = .050,
and TD groups t(57) = -3.289, p = .002. Age was therefore taken into account as a covariate.
ASD participants were diagnosed according to a consensus diagnosis determined by Diag-
nostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria (APA, 2013),
a clinical intake with a child and adolescent psychiatrist or licensed psychologist, and standard-
ized assessments including the Autism Diagnostic Observation Schedule, Second Edition
(ADOS-2)[31] and the Autism Diagnostic Interview-Revised(ADI-R)[32]. Participants in the
ASD group received genetic testing (chromosomal microarray analysis) and were only
included if there was no genetic finding. All SIBS included in this study had an affected sibling
with idiopathic ASD.
Cognitive functioningwas measured in the ASD group using the Stanford-Binet Intelligence
Scales, Fifth Edition (SB-5) [33], the Differential Ability Scales, Second Edition (DAS-II) [34],
or for minimally verbal children, the Mullen Scales of Early Learning [35]. In order to examine
the relationship between IQ and neural responses, this study included children with ASD of
varying levels of cognitive functioning.Adaptive functioningwas measured using the Vineland
Adaptive Behavior Scales, Second Edition (VABS-II), Survey Interview Form [36] (Table 1).
Participants in the TD and SIBS groups were screenedwith the Social Responsiveness Scale,
Second Edition (SRS-2) [37]. Total scores on the SRS-2 were significantly higher in the ASD
group compared to both TD, p< .001, and SIBS groups, p< .001. There was no significant dif-
ference in SRS-2 total scores between the TD and SIBS groups, p = .528. Informed written con-
sent was obtained from all caregivers and assent was obtained from children seven years or
older when appropriate. The Mount Sinai Program for the Protection of Human Subjects
approved the experiments.
VEP Recording
A Neucodia system (VeriSci. Corp., USA) was used for stimulus presentation and data collec-
tion. Gold-cup electrodeswere placed on the midline of the scalp based on the International
10–20 system, which includes an active electrode at Oz (occipital), a reference electrode at Cz
(vertex), and a ground electrode at Pz (in betweenOz and Cz) [38]. These three electrodes com-
prised a single electrophysiological channel. All EEG’s were recorded synchronized to the
Transient Visual Evoked Potentials in ASD
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display’s frame rate. The Neucodia system provided automated artifact detection, which deter-
mined whether the EEG recording was affected by excessive 60-Hz noise or drift/saturation.
For short-duration tests, if an artifact was detected, the EEG epoch was deleted automatically
and the examiner was prompted to repeat the run. For the standard single-trial run, the com-
plete 60-second stimulus was repeated if an artifact was present. An operator verification func-
tion and an infrared camera with a separate monitor enabled the examiner to monitor gaze
fixation and determine whether participants were attending to the screen. The EEG was ampli-
fied (gain = 20,000, bandpass filter: .5–100 Hz) and digitized.
Stimuli
Stimulus field size subtended 10° x 10° of visual angle (viewing distance = 114 cm). Space-aver-
age luminance was ~50 cd/m2 and the frame rate was 150 Hz. A checkerboard pattern consist-
ing of 32 x 32 checks (check size = 18.75 minarc) was contrast reversed with a 1-Hz square-
wave signal (100% contrast). Two versions of the contrast-reversing checkerboardwere admin-
istered, including a standard stimulus displayed for 60 seconds [29] and a new short-duration
condition in which ten three-second (~1 s adaptation and 2-s EEG epoch) runs were obtained
[30]. The order of stimulus presentation alternated between subjects.
VEP Procedures
A visual schedule was used to explain the VEP procedure to all participants. Three surface elec-
trodes were applied to the scalp using water-soluble electrode paste. Participants sat at a view-
ing distance of 114 cm and were prompted to fixate on a crosshair in the center of the display
screen. An auditory signal cued participants prior to each stimulus presentation. An infrared
camera was used to ensure that participants were fixating on the screen and a research assistant
was present at all times to aid in behavior management. All participants had normal (20/20) or
corrected to normal visual acuity at the viewing distance of 114 cm.
Analysis
Time-domain analyses. A discrete Fourier transform was applied to the EEG data to
extract harmonic frequency components of the response, and waveforms were reconstructed
Table 1. Characteristics of ASD Participants.
Characteristic M (SD)
Nonverbal IQ 88.92 (25.23)
Range: 42–140
Verbal IQ 80.22 (23.51)
Range: 40–122
ADOS-2 Social Affect Domain 11.12 (4.17)
ADOS-2 Repetitive, Restricted Behavior Domain 4.44 (2.11)
ADOS-2 Total Score 15.56 (5.70)
ADOS-2 Severity Score 7.41 (2.05)
ADI-R Social Domain 18.48 (5.79)
ADI-R Communication Domain 15.93 (4.92)
ADI-R RRB Domain 7.04 (2.37)
Vineland-II Adaptive Behavior Composite 77.39 (9.26)
IQ and Vineland-II scores are listed as standard scores. ADOS-2 and ADI-R scores are listed as raw scores.
doi:10.1371/journal.pone.0164422.t001
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using even harmonics 2–84 Hz, minus the 60 Hz component. The contrast-reversing checker-
board stimulus used in this study produces a positive peak at approximately 60 ms (P0 or P60),
which reflects activation of the primary visual cortex from the lateral geniculate nucleus. A neg-
ative trough at approximately 75 ms (N0 or N75) reflects depolarization and putative glutama-
tergic postsynaptic activity spreading to the superficial layers of primary visual cortex, and a
positive peak at approximately 100 ms (P1 or P100) reflects superficial hyperpolarization and
putative GABAergic activity [10]. Multivariate analyses of variance (MANOVAs) were used to
assess differences among groups for amplitude (peak-to-trough) and latency (peak time).
Frequency-domainanalyses. Amagnitude-squared coherence (MSC) statistic was used to
quantitatively assess the integrity of overall responses in different frequency bands. Mean MSC
values for each band were calculated based on previous work using principal component analy-
sis, which identified the relevant frequency bands [39]. The six distinct frequencymechanisms
include: Band 1, 6–10 Hz; Band 2, 12–28 Hz; Band 3, 30–36 Hz; Band 4, 38–48 Hz; Band 5, 50–
64 Hz, minus 60 Hz; Band 6, 66–84 Hz. Band 1 reflects alpha-wave activity, Band 2 reflects
beta-wave activity, and Bands 3–6 reflect gamma-wave activity. MSC refers to the reliability of
the response and estimates signal power/signal+noisepower. MSC was calculated to determine
consistency from one trial to the next in both size and at a given frequency. A pure signal
would yield a value of 1 and no signal would produce a value about 0.1 (bias level for pure
noise given ten EEG epochs).MANOVAS were run to examine Group x Frequency Band inter-
actions. Intraclass correlation coefficients (ICCs) were obtained to assess the reliability of
responses between the standard- (60-s) and short-duration conditions.
Results
All 96 participants in the final sample completed at least one of the two stimulus conditions.
The standard condition was completed by 25 participants with ASD, 28 TD participants, and
23 SIBS. The short-duration condition was completed by 34 children with ASD, 30 TD chil-
dren, and 22 SIBS.
Time-domain analyses
There were no group differences in the latency of responses at P60, N75, or P100. Amplitudes
were measured from peak to trough, P60-N75 and N75-P100 (Table 2). Results indicated a signif-
icant main effect by group for amplitude in response to both the standard 60-s contrast-revers-
ing checkerboard condition [F(4,146) = 3.755, p = .006] and the short-duration condition [F
(4,166) = 5.260, p = .001].
Table 2. Amplitude and Latency.
Standard Condition Short-Duration Condition
Amplitude (μV) Latency (ms) Amplitude (μV) Latency (ms)
Group P60-N75* N75-P100* P60 N75 P100 P60-N75* N75-P100* P60 N75 P100
ASD 7.75 17.91 53.00 71.40 102.40 9.80 20.01 52.06 71.12 99.94
(3.66) (6.79) (4.87) (3.30) (7.70) (5.59) (9.33) (4.85) (4.30) (7.57)
TD 15.00 29.62 51.32 69.68 100.46 18.99 33.27 51.40 70.33 100.20
(8.29) (15.64) (5.84) (3.39) (7.47) (11.05) (15.44) (6.03) (3.74) (8.09)
SIBS 13.15 25.43 51.39 71.13 103.74 16.53 29.95 51.14 69.27 101.68
(7.91) (12.56) (3.46) (4.03) (8.18) (8.55) (11.66) (3.20) (3.88) (9.13)
Values are presented as mean (standard deviation) for the standard 60-s contrast-reversing checkerboard condition and the short-duration condition
consisting of ten trials (3-s each). Asteriks indicate p-values < .05.
doi:10.1371/journal.pone.0164422.t002
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For the standard condition, significant univariate main effects were obtained for both P60-
N75 [F(2,74) = 7.586, p = .001] and N75-P100 [F(2,74) = 6.040, p = .004] amplitudes. Pairwise
comparisons showed that the ASD group had significantly smaller amplitudes than the TD
group for P60-N75 (p< .001) and N75-P100 (p = .001). Amplitudes in the ASD group were also
significantly smaller compared to SIBS for both P60-N75 (p = .009) and N75-P100 (p = .040).
The short-duration condition produced the same result. Significant univariate main effects
for amplitude were obtained for P60-N75 [F(2,84) = 10.369, p< .001] and N75-P100 [F(2,84) =
9.839, p< .001]. Pairwise comparisons indicated that the difference was driven by significantly
smaller amplitudes in the ASD group compared to the TD group for P60-N75 (p< .001) and
N75-P100 (p< .001). The ASD group also showed significantly smaller amplitudes than the
SIBS group for P60-N75 (p = .004) and N75-P100 (p = .005). There were no significant differences
in amplitude betweenTD and SIBS groups, although SIBS did show responses between that of
the ASD and TD groups (Figs 1 & 2).
Fig 1. Mean Amplitude by Group. Children in the ASD group showed significantly smaller P60-N75 and N75-P100
amplitudes on both the standard condition and the short-duration condtition compared to the TD and SIBS groups.
Significance bars indicate p-values < .05. Error bars: +/- 1 SE.
doi:10.1371/journal.pone.0164422.g001
Transient Visual Evoked Potentials in ASD
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There were no significant Pearson correlation coefficients between amplitude measures and
IQ or age in the ASD group (all p-values> .05). Furthermore, results persisted when age and
sex were taken into account as covariates.
Frequency-domain analyses
There was a significantmain effect by group for both the standard condition [F(12, 166) =
2.201, p = .014] and the short-duration condition [F(12, 172) = 2.008, p = .026]. For the stan-
dard condition, significant univariate main effects were obtained for Band 2 (p = .003), Band 3
(p = .003), Band 4 (p = .037) and Band 5 (p = .006). Similarly, for the short-duration condition,
significant univariate main effects were obtained for Band 2 (p = .0468) and Band 3 (p = .001),
and approached significance for Band 4 (p = .054) and Band 5 (p = .054). Pairwise comparisons
Fig 2. Amplitude by Individual. Scatterplots depict individual amplitude values by group for the standard and short-duration condition. Significance bars
indicate p-values < .05.
doi:10.1371/journal.pone.0164422.g002
Transient Visual Evoked Potentials in ASD
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indicated that results were driven by significantly weaker responses in these bands for the ASD
group relative to TD and SIBS groups (Fig 3).
Reliability between conditions
A two-level linear mixed-effectsmodel was used to measure the absolute agreement across
stimulus conditions within an individual. The covariance structure was variance components.
Observerwas treated as a random effect and stimulus condition was a fixed effect. Reliability of
individual observerswas strong for amplitude and latency measures with ICCs all> .85. ICCs
for MSC bands were significant for Bands 1–5, with strong correlations for Bands 2, 3, and 4
(Table 3).
Discussion
This study applied electrophysiological techniques to examine early-stage visual processing in
children with idiopathic ASD and their unaffected siblings. Low-level visual stimuli were used
Fig 3. Mean magnitude squared coherence (MSC) by Group. Mean MSCs are displayed for the standard
condition. Significance bars indicate p-values < .05. Error bars: +/- 1 SE.
doi:10.1371/journal.pone.0164422.g003
Transient Visual Evoked Potentials in ASD
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to examine tVEP responses to a standard contrast-reversing checkerboard condition and a
novel short-duration condition. The new stimulus condition was developed to improve objec-
tive data collection from severely affected or difficult to test populations, who are often
excluded from EEG studies due to the cognitive, receptive language, or behavioral demands
essential to many protocols. For this reason, children with ASD of varying levels of cognitive
and adaptive functioningwere included.
Results from time-domain analyses indicate that children with ASD display significantly
smaller amplitudes than both TD children and SIBS for two of the earliest, critical VEP compo-
nents, P60-N75 and N75-P100, which reflect primarily excitatory and inhibitory postsynaptic
activity, respectively. These results add to a growing body of literature indicating reduced corti-
cal activity in ASD [40–44]. The smaller P60-N75 amplitude found in the ASD group suggests
weaker excitatory input to the cortex, which subsequently reduces the inhibitory component of
the VEP. N75-P100 amplitude is a measure of the relative strength of inhibition to excitation.
The loss of excitatory input seen in the ASD group was proportional to the loss of inhibitory
input observed,which suggests that there is not a significant deficit in intracortical inhibition.
If excitation was intact and decreased inhibition was present, we would expect significantly
larger P60-N75 amplitudes. In this case, weaker input to the cortex reflects excitatory deficits,
which subsequently result in less inhibition and an overall reduction in amplitude for both crit-
ical components.Response latencies did not differ among groups as all groups reached P60, N75,
and P100 peaks and troughs within expected time intervals. These results indicate that there
was no measureable delay in information getting to the visual cortex in the ASD group.
The greater loss in higher frequency activity in the ASD group may be due to the attenuated
excitatory input to the cortex observed in this group. A loss in excitatory input is expected to
lead to decreased intracortical synaptic activity and subsequent to that, reduced conductance
across neuronal membranes, which would yield longer time constants and a loss in high fre-
quency activity [45]. While our results suggest a loss of excitatory input at the cortical level,
studies examining high frequency excitatory input to the cortex are currently underway to
determine whether there is a high-frequency loss in cortical input or if the high-frequency loss
is produced in the cortex.
Results from frequency-domain analyses provide additional support for decreased cortical
responses in ASD. While time-domain analyses offer important information with regard to the
Table 3. Intraclass Correlation Coefficients (ICC) for Time- and Frequency-Domain Variables.
ICC p
P60-N75 Amplitude .920 < .001
N75-P100 Amplitude .889 < .001
N75 Latency .873 < .001
P100 Latency .892 < .001
Band 1 .445 .002
Band 2 .717 < .001
Band 3 .817 < .001
Band 4 .785 < .001
Band 5 .371 .010
Band 6 . 165 .183
Results show the consistency between the standard condition and short-duration condition. Frequency
bands include the following: Band 1, 6–10 Hz; Band 2, 12–28 Hz; Band 3, 30–36 Hz; Band 4, 38–48 Hz;
Band 5, 50–64 Hz, minus 60 Hz; Band 6, 66–84 Hz.
doi:10.1371/journal.pone.0164422.t003
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magnitude and timing of responses, frequency-domain analyses are a more objectivemeasure
of the consistency of responses within different frequency components and bands. Our results
indicate that children with ASD display greater response variability in bands encompassing
both low (Band 3) and higher gamma-wave (Band 4) activity. Alterations in gamma oscilla-
tions within the visual cortex have been attributed to waveform abnormalities in clinical popu-
lations [46] and have been correlated with VEP responses, which may indicate that the neural
populations generating these responses are the same [47]. In addition, although no studies
have applied frequency-band analyses to tVEPs in ASD, these findings are consistent with
EEG, magnetoencephalography (MEG), and functionalmagnetic resonance imaging (fMRI)
studies describing abnormal gamma oscillations in several different brain regions [48–50], and
may reflect some of the functional impairments observed in ASD. There is also literature
describing the relationship between gamma-wave activity and GABAergic interneurons,
including the potential role of gamma-band activity as an endophenotype that may be used to
detect response to treatment [51]. While our VEP results may not reflect the same brain mech-
anisms examined when looking at ongoing, resting-state EEG or higher order visual stimuli,
there could be overlap in visual responses and natural circuitry in the brain.
Future work applying stimulus conditions that measure nonlinear lateral and shunting
inhibitory interactions can be used to explore the quality of specific inhibitorymechanisms in
ASD [45, 52].Understanding the morphology of GABAergic neurons that are responsible for
shunting inhibition versus those that play other inhibitory roles in the nervous system are
important to better understand the E/I abnormalities found here, which suggest reduced inhib-
itory activity as a result of weaker excitatory input to the cortex.
With regard to the SIBS group, there were no differences in the amplitude or latency of
responses relative to the TD group; however SIBS showed significantly stronger responses than
their affected siblings and non-significant, but weaker responses than controls for response
amplitudes. This pattern of intermediate brain activity is consistent with previous literature in
unaffected siblings of individuals with ASD [53, 54]. Interestingly, there were no frequency
domain differences between the SIBS and TD groups. This profile in which SIBS display inter-
mediate amplitudes in relation to TD and SIBs groups with high reliability of responses
requires further exploration into the potential role of an endophenotype.
The novel short-duration condition, which was created to enable data collection from
severely affected or difficult to test populations, is a main contribution of this study. The short-
duration condition allows for repeated trials with breaks as needed, requiring only three sec-
onds of sustained attention per trial. Approximately 30 seconds of testing under this demon-
strated comparable VEP data with respect to amplitude, latency, and early/mid-frequency
band activity compared to a standard 60-s condition. In addition, data from the short-duration
stimulus was collected from approximately 92% of children with ASD, compared to 68% for
the standard stimulus. It is also notable that data collectionwas feasible from children with sig-
nificant impairments in language and intellectual functioning.Given the critical need for objec-
tive outcome measures, the short-duration conditionmay be a helpful new tool for a variety of
clinical disorders. In addition, consistent findings between the two stimulus conditions, specifi-
cally, the combination of smaller tVEP amplitudes and reduced frequency band activity may
signify a diagnosticmarker of ASD and warrants continued evaluation.
Overall, time- and frequency-domain analyses did not demonstrate a relationship between
cognitive ability and age with VEP responses, suggesting that the differences observedhere
might be a marker of ASD broadly and, importantly, are not a consequence of intellectual func-
tioning or development. However, given the heterogeneity of the disorder, further studies are
needed in order to subgroup individuals based on neurophysiological profiles. In addition,
while IQ is not expected to affect responses at such early stages of sensory processing, a
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comparison group of children with developmental delay and/or intellectual disability without
ASD would enhance the generalizability of these findings. Future studies should examine VEPs
longitudinally to determine whether developmental changes are present and whether there are
differences in neural maturation between individuals with and without ASD. Finally, while
there were significant differences among group means for the amplitude of VEP responses,
analyses at an individual level are necessary for subtyping individuals with ASD based on excit-
atory/inhibitory (E/I) profiles. This type of subtyping may be an important future direction to
determine appropriate treatment targets for a given individual. Future work should also
include infant-sibs studies, which have the potential to offer important information on the util-
ity of tVEPs as an early diagnosticmarker of ASD while providing information on endopheno-
types based on SIBS responses.
In the long-term, VEPs may be useful for clinical trials and testing the efficacy of medica-
tions that affect glutamatergic or GABAergic systems. Baseline VEP responses could be used as
inclusionary criteria (e.g., choosing participants with weak excitatory responses) and then
applied as an outcome measure or a method to gather information on change and possibly
optimal drug dosage. The results of the current study may provide some explanation for the
failure of many clinical trials in ASD, as the heterogeneity of the disorder requires personalized
approaches and objective outcome measures.
Overall, VEPs are advantageous as they are a rapid, reliable, and well-understoodmethod to
gather information about postsynaptic brain activity. VEPs can be obtained using only a single
electrophysiological channel (three electrodes), as was done in this study, and have been used
on infants in the first few weeks of life [55–57]. In addition, a Current Procedural Terminology
(CPT) code for VEPs already exists, adding to the potential clinical utility of these methods.
Longitudinal natural history studies are needed to determine when abnormalities emerge and
whether they are present throughout the lifespan. Correlating neural findings from diffusion
tensor imaging (DTI) studies of the optic nerve as well as magnetic resonance spectroscopy
(MRS) studies examining GABA levels in the visual cortex are also essential next steps.
The current study establishes the utility of a short-duration tVEP test for use in children
with ASD at varying levels of functioning. In addition, specific deficits were observed including
reduced amplitudes at the two earliest critical peaks in the tVEP waveform and weaker
responses in gamma-band activity, which play an important role in balanced excitation and
inhibition. The methods used in this study may be integrated into future clinical trials to assess
the efficacy of VEPs as a measure of change in response to treatment or a predictor of treat-
ment response. This is the first known study to examine VEPmarkers in a sample inclusive of
children with comorbid intellectual disability and behavioral challenges, while establishing the
utility of a novel short-duration VEP test for use in this population.
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